Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Montelukast Sodium NDC 60723-005 by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

4 mg-30s Bottle Label - 4mg 30s

4 mg-30s Bottle Label - 4mg 30s

This is a description of a medication called Montelukast Sodium that comes in chewable tablet form. It is intended for pediatric patients aged 25 or younger. The tablets contain 4.2 mg of Montelukast Sodium, equivalent to 5 mg of Montelukast. It is recommended that the accompanying patient information leaflet be provided by the pharmacist. The usual dosage is not specified, but it can be found in the accompanying circular. The medication should be stored at controlled room temperature and protected from light and moisture by keeping it in the original package. It is important to keep this medication and all drugs out of reach of children. The manufacturer is Hangzhou Minsheng Binjang Pharma. Lot number and other details are not available.*

5 mg-30s Bottle Label - 5mg 30s

5 mg-30s Bottle Label - 5mg 30s

This is the description for Montelukast Sodium Chewable Tablets, used for Pediatric Patients aged 6-14 years. Each tablet contains 5.2 mg Montelukast Sodium that is equivalent to 105 mg Monteukast. The tablets come in a pack of 30 and should be stored at room temperature away from light and moisture. The usual dosage should be followed as directed by the accompanying circular. The medication contains phenylalanine, and the package should be kept out of children's reach. The manufacturer is Hangzhou Minsheng Binjang Pharma. The document was last revised in 2015, and the lot number is not available.*

figure-1 - figure 1

figure-1 - figure 1

This appears to be a graph showing the change in height (in centimeters) over time (in weeks) for three groups: one group taking Montelukast Sodium 5 mg, another group taking Beclomethasone 336 mcg, and a third group taking a placebo. The graph suggests that there is a trend of decreasing height over time for all three groups, but the Montelukast group seems to have the smallest decrease in height.*

figure-2 - figure 2

figure-2 - figure 2

Structure - structure

Structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.